Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report.
J Med Case Rep
; 13(1): 245, 2019 Jul 25.
Article
in En
| MEDLINE
| ID: mdl-31340860
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ameloblastoma
/
Protein Kinase Inhibitors
/
Vemurafenib
/
Lung Neoplasms
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
J Med Case Rep
Year:
2019
Document type:
Article
Affiliation country:
France
Country of publication:
United kingdom